When did Beam Therapeutics report Q4 2024 earnings?

Beam Therapeutics (BEAM) reported Q4 2024 earnings on February 25, 2025 before market open.

What were Beam Therapeutics's Q4 2024 revenue and EPS?

Beam Therapeutics reported revenue of $30.1M and eps of $-1.09 for Q4 2024.

Did Beam Therapeutics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $16.5M by $13.6M. EPS beat the consensus estimate of $-1.25 by $0.16.

Where can I find Beam Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-026076) directly on SEC EDGAR. The filing index links above go to sec.gov.

Beam Therapeutics BEAM Q4 2024 Annual earnings

Reported February 25, 2025 · Before market open

Revenue$30.1MBeat by $13.6M

EPS-$1.09Beat by $0.16

Revenue estimate$16.5M

EPS estimate-$1.25

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$16.4M

EPS estimate-$1.11

Financials

Q4 2024

Income statement

See full

Revenue$30.1M-90.5%

Operating income-$100.0M—

Net income-$90.4M—

EPS (diluted)-$1.09—

Balance sheet

See full

Cash & equivalents$282.0M-35.3%

Total debt$161.4M-6.5%

Total equity$733.5M-25.2%

Total assets$1.1B-24.4%

Cash flow

See full

Operating cash flow-$76.4M—

CapEx$3.0M-17.2%

Free cash flow-$79.3M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.05B-7.4%

Enterprise value$1.93B-1.1%

P/S32.3×+26.5×

Profitability

See full

Operating margin-654.3%—

Net margin-593.1%—

FCF margin-560.8%—

Returns & leverage

See full

Return on equity-43.9%—

Debt / equity0.2×0.0×

Current ratio4.8×-1.1×

Versus estimates

Revenue

Q1 2026$31.7MBeat by $20.8M Q4 2025$114.1MBeat by $102.4M Q3 2025$9.7MMiss by $3.5M Q2 2025$8.5MMiss by $3.1M Q1 2025$7.5MMiss by $8.0M

Q4 2024$30.1MBeat by $13.6M

Diluted EPS

Q1 2026-$0.91Miss by $0.04 Q4 2025-$0.10Beat by $1.03 Q3 2025-$1.10Miss by $0.12 Q2 2025-$1.00Beat by $0.04 Q1 2025-$1.24Miss by $0.13

Q4 2024-$1.09Beat by $0.16

Ask the moment Beam Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Beam Therapeutics report Q4 2024 earnings?: Beam Therapeutics (BEAM) reported Q4 2024 earnings on February 25, 2025 before market open.
What were Beam Therapeutics's Q4 2024 revenue and EPS?: Beam Therapeutics reported revenue of $30.1M and eps of $-1.09 for Q4 2024.
Did Beam Therapeutics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $16.5M by $13.6M. EPS beat the consensus estimate of $-1.25 by $0.16.
Where can I find Beam Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-026076) directly on SEC EDGAR. The filing index links above go to sec.gov.